NOCIL Q1FY27: Growth returns, margins improve, and the TDQ ramp begins

NOCIL Limited started FY27 on a stronger footing, reporting consolidated net revenue from operations of 403 crore in Q1FY27, up 20% year on year. Profitability improved faster than revenue. Operating EBITDA rose to 45 crore and the operating EBITDA margin expanded to 11.2%, compared with 9.1% in Q1FY26 and 6.4% in Q4FY26. Net profit came in at 28 crore, up 61% year on year.

The quarter was shaped by a combination of steady end-market demand, higher average selling prices linked to raw material inflation, and operating leverage. It was also a quarter where execution was tested. Sequential volumes declined 3% due to supply-side constraints in utilities and logistical challenges amid the ongoing geopolitical situation, which pushed some order commitments into later periods.

Volume-led growth year on year, but supply constraints hit sequential performance

Management highlighted that Q1FY27 volumes grew 9% compared to Q1FY26. Domestic volumes grew in double digits, which management linked to improved demand supported by the implementation of GST 2.0. Export volumes grew in single digits, driven by conversion of ongoing customer engagements into business gains. On mix, the company indicated exports were about 33% and domestic about 67% of volumes in Q1.

Sequentially, the narrative was more operational than cyclical. Revenues grew 22% quarter on quarter to 403 crore, but volumes fell 3% because of utility constraints and logistics disruptions. Management characterized these as operational and not demand-led, and stated it is working with suppliers and logistics partners to normalize supplies and execute deferred orders.

Profitability rebound, with one-offs in conversion costs

Operating performance improved sharply. Value addition rose to 175 crore in Q1FY27 versus 143 crore in Q1FY26, and operating EBITDA increased to 45 crore from 31 crore. Management also addressed the rise in conversion costs sequentially. The CFO cited higher freight costs due to the Middle East crisis, elevated gas prices and gas availability issues affecting utilities, operational throughput constraints, higher CSR spends typically incurred early in the year, and certain maintenance issues described as one-time in nature.

While the company expects some moderation in realizations from Q1 levels, management expects FY27 EBITDA to hover around 10%, helped by a combination of volume growth, domestic realization improvement in accelerators, product mix, and operating leverage.

Financial snapshot

Portfolio expansion and Dahej capex: TDQ ramp becomes the next monitorable

The investor presentation frames NOCIL’s strategy around five pillars, with product portfolio expansion and operational excellence as major themes. A key near-term catalyst is the new TDQ facility at Dahej.

Management stated that trial production at the TDQ plant is progressing well and samples have been initiated with customers. The expected ramp is tightly linked to customer approvals. Management reiterated that approvals typically take around six to eight months. Based on this, the company expects volumes to start trickling in during Q4FY27, with a more meaningful ramp into Q1 of the next financial year. Management also confirmed that revenues from the TDQ plant are expected within FY27.

Alongside TDQ, the presentation outlines two Dahej capex programs.

First, an announced 250 crore capex program, which the company described as underscoring long-term commitment to growth in rubber chemicals, with the plant already in trial production and samples sent for approval.

Second, a 130 crore brownfield capex program announced in March 2026 to expand capacity for peak-utilization rubber chemical products through an integrated facility including backward integration of its inputs. The company targets completion by H1FY28 and expects funding largely through internal accruals. Management added that progress remains on track despite disruptions connected to the war.

Policy support via anti-dumping, but benefit depends on market behavior

Anti-dumping duty developments remain an important variable for the domestic market, especially in accelerators.

Management stated that the Central Government approved the imposition of anti-dumping duty on Sulphonamides covering both CBS and NS on 20 June 2026. For Pilflex 13, the DGTR issued a positive final recommendation in June 2026, and the final implementation is subject to Government of India approval.

When asked about the extent of the portfolio that could be covered by anti-dumping duties, management indicated that excluding TDQ, products under the notified and potential anti-dumping umbrella would be about 25% to 30% of the business. However, the company refrained from quantifying the margin impact at this stage, noting that outcomes depend on how much foreign producers absorb versus pass through.

FY27 guidance sets the frame: revenue 1400 to 1600 crore, EBITDA around 10%

For FY27, management guided revenue in the range of 1400 to 1600 crore based on the current pricing environment, with EBITDA in the region of 10%. On volumes, management discussed an assumption of around 10% growth for the full year.

The company also noted continued uncertainty in raw material pricing and availability due to geopolitics. At the same time, management stated it is not seeing any significant impact on demand yet, and expects the positive momentum to sustain, with deferred volumes recovering in subsequent quarters.

Key takeaways

NOCIL’s Q1FY27 print shows a clear improvement in operating performance, with margin expansion supported by higher value addition and operating leverage. The operational headwinds that reduced sequential volumes appear execution-related rather than demand-led, which matters for the durability of the recovery.

For investors tracking the next leg, three markers stand out: how quickly deferred volumes get delivered as logistics stabilize, the cadence of TDQ approvals and early commercial shipments, and whether anti-dumping measures translate into improved realizations or are competed away through importer absorption. FY27 guidance provides a measurable frame, but the operating environment remains sensitive to geopolitics and input-cost swings.